期刊文献+

白细胞介素-17在糖尿病大鼠肾组织中表达与肾小管-间质病变的关系 被引量:4

Association between interleukin-17 expression in renal tissue of rats with diabetic nephropathy andrenal tubulointerstitial lesions
原文传递
导出
摘要 目的观察白细胞介素-17(IL-17)在糖尿病大鼠肾组织中的表达,探讨其与肾小管-间质病变的关系。方法90只大鼠随机分为对照组(Con组)、1型糖尿病组(T1DM组)及2型糖尿病组(T2DM组),以50mg/kg链脲佐菌素(STZ)制备1型糖尿病模型,以高脂高糖饮食及25mg/kgSTZ制备2型糖尿病模型。于2周、4周末采用酶联免疫吸附试验(ELISA)检测血、尿中IL-17水平;4周末采用免疫组织化学染色及Westernblot检测肾组织中IL-17及转化生长因子-B1(TGF-131)水平。结果糖尿病大鼠2、4周末m、尿中IL。17升高;IL-17在Con组。肾组织无表达,仅在糖尿病大鼠肾小管-问质中表达,TIDM组0.2357±0.0410,T2DM组0.1809±0.0090(P〈0.05);TGF-131肾组织表达,T1DM组0.1412±0.0610,T2DM组0.2809±0.0420(P〈0.05);肾组织IL-17与尿液IL-17水平呈正相关(r=0.715,P〈0.05)。结论IL-17参与糖尿病肾小管-问质病变的发生;IL-17和TGF-/B1在1型和2型糖尿病发展为糖尿病肾病中的作用机制存在差异。 Objective To investigate the association between the expression of interleukin-17 ( IL-17 ) in renal tissues of rats with diabetic nephropathy and tubulointerstitial lesions. Methods Ninety rats were randomly divided into three groups: control group, type 1 diabetic mellitus (T1DM) group, and type 2 diabetic mellitus (T2DM) group. The rats in T1DM group were given 50 mg/kg streptozotiein (STZ) , and those in T2DM group fed on a diet enriched with sucrose, triglyceride and cholesterol, and in- jected with 25 mg/kg STZ. At 2nd and 4th week, serum and urine IL-17 levels were determined by using enzyme-linked immunosorbent assay (ELISA). The expression of IL-17 and transforming growth factor-131 ( TGF-B1 ) in the kidney was detected by using immunohistoehemisty staining and Western blotting. Results Serum and urine IL-17 levels were obviously increase in diabetic rats. The expression of IL-17 was detectable in renal tubulointerstitium of diabetic rats. The expression of IL-17 in T2DM and T1DM groups was 0. 1809 ±0. 0090 and O. 2357 ±0. 0410 respectively (P 〈0. 05). The expression of TGF-B1 in T2DM and T1DM groups was 0. 2809 ± 0. 0420 and 0. 1412 ± 0. 0610 respectively ( P 〈 0.05 ). The expression of IL-17 in renal tubulointerstitium of diabetic rats was positively correlated with urine IL-17 (r = 0. 715 ,P 〈 0. 05 ). Conclusion The increase of IL-17 expression may play an important role in diabetes mellitus-in- dueed tubulointerstitial lesions. IL-17 and TGF-[31 might exert different effects on pathogenesis and pro- gression of diabetic nephropathy from T1DM and T2DM.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第2期342-344,F0004,共4页 Chinese Journal of Experimental Surgery
基金 湖北省自然科学基金资助项目(2012FFB04306)
关键词 白细胞介素-17 糖尿病 转化生长因子-B1 Interleukin-17 Diabetes mellitus Transforming growth faetor-B1
  • 相关文献

参考文献10

  • 1Fornoni A,Ijaz A,Tejada T. Role of inflammation in diabetic nephropathy[J].Curr Diabetes Bey,2008.10-17.
  • 2郭啸华,刘志红,李恒,黎磊石.高糖高脂饮食诱导的2型糖尿病大鼠模型及其肾病特点[J].中国糖尿病杂志,2002,10(5):290-294. 被引量:304
  • 3Nangaku M. Mechanisms of tubulointerstitial injury in the kidney:final common pathways to end stage renal failure[J].Internal Medicine,2004.9-17.
  • 4Goldberg RB. Cytokine and cytokine-like inflammation markers,endothelial dysfunction,and imbalanced coaguldation in development of diabetes and its complications[J].Journal of Clinical Endocrinology and Metabolism,2009.3171-3182.
  • 5魏文,李娟娟,孙圣荣,王卫星.乳腺癌小鼠动物模型中白细胞介素-17的表达及其意义[J].中华实验外科杂志,2011,28(5):673-675. 被引量:11
  • 6张金野,李书红,王俊,林国和,李升平.白细胞介素-17和白细胞介素-6在肝内胆管细胞癌的表达及其临床意义[J].中华实验外科杂志,2012,29(2):243-246. 被引量:3
  • 7Hills CE,Squires PE. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy[J].Cytokine & Growth Factor Reviews,2011.131-139.
  • 8Veldhoen M,Hocking R J,Atkins C J. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells[J].Immunity,2006,(2):179-189.doi:10.1016/j.immuni.2006.01.001.
  • 9Sutherland AP,Van Belie T,Wurster AL. Interleukin-21 is required for the development of type 1 diabetes in NOD mice[J].Diabetes,2009.1144-1155.
  • 10Gorelik L,Flavell RA. Transforming growth factor-βin T cell biology[J].Nature Reviews Immunology,2002.46-53.

二级参考文献23

  • 1Soresi Maurizio,Giannitrapani Lydia,D'Antona Fabio,Florena Ada Maria,La Spada Emanuele,Terranova Angela,Cervello Melchiorre,D'Alessandro Natale,Montalto Giuseppe.Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(16):2563-2568. 被引量:25
  • 2姚晓莉,童鹤翔,涂毅,姚峰,王卫星,孙圣荣.CCL5及其受体在乳腺癌组织中的表达及其意义[J].中华实验外科杂志,2007,24(5):590-592. 被引量:15
  • 3Afzali B,Lombardi G,Lechler HI,et al.The role of T helper 17 (Th 17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.Clin Exp Immunol,2007,148:32-46.
  • 4Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6:1123-1132.
  • 5Fossiez F,Banchereau J,Murray R,et al.Interleukin-17.Int Rev Immunol,1998,16:541 -551.
  • 6Zhang B,Rong G,Wei H,et al.The prevalence of Thl7 cells in patients with gastric cancer.Biochem Biophys Res Commun,2008,374:533-537.
  • 7Le Gouvello S,Bastuji-Garin S,Aloulou N,et al.High prevalence of Foxp3 and IL-17 in MMR-proficient colorectal carcinomas.Gut,2008,57:772-779.
  • 8Numasaki M,Watanabe M,Suzuki T,et al.IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenes(i)s.J Immunol,2005,175:6177-6189.
  • 9Shime H.Yabu M.Akazawa T,et al.Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway.J Immunol,2008,180:7175-7183.
  • 10Kryczek I,Wei S,Zou L,et al.Cutting edge:Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.Immunol,2007,178:6730-6733.

共引文献315

同被引文献14

  • 1Fornoni A, Ijaz A, Tejada T, et al. Role of inflammtion in diabetic nephropathy[ J ]. Curt Diabetes Rev,2008,4 : 10-17.
  • 2Baban B, Liu JY, Mozaffari MS. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy : role of indoleamine 2, 3-dioxygenase and programmed death-l[J]. Exp Mol Pathol,2013,94:343-351.
  • 3Bikle DD. Vitamin D regulation of immune function [ J ]. Vitam Horm,2011,86:1-21.
  • 4Miossec P. IL-17 and Thl7 cells in human inflammatory diseases [ J ]. Microbes Infect, 2009,11:625-630.
  • 5Martin-Orozco N, Chung Y, Chang SH, et al. Thl7 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Thl cells [ J ]. Eur J Immuno1,2009 ,39 :216-224.
  • 6Deteix C, Attuil-Audenis V, Duthey A, et al. Intragraft Thl7 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection[J]. J Immunol,2010,184:5344-5351.
  • 7Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile [ J ]. J Pharmacol Exp Ther, 2008,324 : 23-33.
  • 8Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T (H)17 lineage [ J ]. Nature.2006.441:231-234.
  • 9陈小奇,徐焱成,邓浩华,孙家忠,代喆,吴玉文,杨杪.辅助性T细胞Th17与1型糖尿病发病的关系[J].中华糖尿病杂志,2011,3(6):472-477. 被引量:11
  • 10郝丽,潘梦舒,郑云,王瑞峰.冬虫夏草及雷公藤多甙对糖尿病肾病大鼠足细胞影响的实验研究[J].中国中西医结合杂志,2012,32(2):261-265. 被引量:25

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部